Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.

David Lorente, David Olmos, Joaquin Mateo, Zafeiris Zafeiriou, Pasquale Rescigno, Diletta Bianchini, Niven Mehra, Arturo Molina, Thian Kheoh, Kurt Baeten, Robert Thomas Mccormack, Leon W.M.M. Terstappen, Howard I. Scher, Johann S. de Bono

Research output: Contribution to journal › Meeting Abstract › Other research output

Fingerprint

Dive into the research topics of 'Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology